An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres "SILVER-AP"


Phase N/A Results N/A

Main Contacts

Name Phone E-mail
Bayer Study Director Study Director
Bayer Clinical Trials Contact Contact

Other Locations

Name City State Country Status
Name Unavailable Many Locations Spain Unknown_status_icon